By Renee Hickman ( June 29, 2023, 3:31 PM EDT) -- Biotech company Tevogen Bio and Semper Paratus, a special purpose acquisition company, announced an agreement to merge on Thursday, which would take the combined company public at a pro forma enterprise value of approximately $1.2 billion, advised by Nelson Mullins and Hogan Lovells....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.